National Stock Number
6505-01-255-9081
National Stock Number (NSN) 6505-01-255-9081, or NIIN 012559081, (calcium gluconate injection) was assigned May 30, 1987 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505000978138.
There are 8 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 6 suppliers. Today, 4 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 4 suppliers are deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Sep 02, 2016. There have been 6 contracts issued for this part number, with 6 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPE2DX15D9383, SPE2DP13D0925, SPE2DP13D0925, SPE2DP13D0925, SPE2DP13D0925. The total value of the awarded contracts has been US$ 27,753.30.
There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Jan 02, 2017, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 31155. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505012559081 does not contain precious metals.
This NSN is associated to Schedule B 3004505010: single vitamins combined with minerals or other nutrients. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.
This information was last updated on Jul 01, 2025.